ANZROD

ANZROD predicts ICU mortality in humans (AUROC 0.90).

“ANZROD demonstrated superior discrimination for ICU mortality (AUROC 0.90) and hospital mortality (AUROC 0.82) compared with SOFA and APACHE III.”

Humans

Critical illness at extreme age: outcomes and clinical characteristics of centenarian ICU admissions in Australia and New Zealand

Critical care (London, England)·25 Mar 2026

ANZROD predicts ICU mortality in humans (AUROC 0.870).

“ANZROD consistently showed the highest discriminative ability, with AUROCs of 0.870 for ICU mortality and 0.768 for 1-month mortality.”

HumansICU admissionn = 40,910

Validity of ICU prognostic risk stratification tools in the oldest patients: a comparative analysis of clinical scores in a multicenter binational cohort

Journal of anesthesia, analgesia and critical care·17 Jan 2026

ANZROD predicts in-hospital mortality in humans (AUROC 0.82).

“and hospital mortality (AUROC 0.82) compared with SOFA and APACHE III.”

Humans

Critical illness at extreme age: outcomes and clinical characteristics of centenarian ICU admissions in Australia and New Zealand

Critical care (London, England)·25 Mar 2026

ANZROD predicts mortality in humans.

“all models showed poor calibration and declining discrimination over longer horizons”

HumansICU admissionn = 40,910

Validity of ICU prognostic risk stratification tools in the oldest patients: a comparative analysis of clinical scores in a multicenter binational cohort

Journal of anesthesia, analgesia and critical care·17 Jan 2026

ANZROD predicts 1-month mortality in humans (AUROC 0.768).

“ANZROD consistently showed the highest discriminative ability, with AUROCs of 0.870 for ICU mortality and 0.768 for 1-month mortality.”

HumansICU admissionn = 40,910

Validity of ICU prognostic risk stratification tools in the oldest patients: a comparative analysis of clinical scores in a multicenter binational cohort

Journal of anesthesia, analgesia and critical care·17 Jan 2026